Literature DB >> 18319561

Cholangiolocellular carcinoma containing hepatocellular carcinoma and cholangiocellular carcinoma, extremely rare tumor of the liver:a case report.

Mami Kanamoto1, Tomoharu Yoshizumi, Toru Ikegami, Satoru Imura, Yuji Morine, Tetsuya Ikemoto, Nobuya Sano, Mitsuo Shimada.   

Abstract

Cholangiolocellular carcinoma (CLC) is an extremely rare malignant liver tumor which was first defined by Steiner, et al. in 1957 (1). CLC is thought to be derived from Hering's canal because tumor glands of CLC are morphologically similar to cholangioles. Recently, Theise, et al. reported that Hering's canal might be composed of hepatic stem cells (3). In addition, CLC sometimes contains a hepatocellular carcinoma (HCC) or cholangiocellular carcinoma (CCC) component within the tumor. Those findings suggest that CLC might originate from hepatic stem cells. On the other hand, because of its low frequency, clinicopatholigical features of CLC have not been fully clarified yet. We herein report a case of a 71-year old man with CLC. Based on preoperative imagings, the hepatic tumor was diagnosed as HCC, and he underwent a partial hepatectomy. The tumor contained both a HCC and CCC-like area. In immunohistochemistry, cytokeratin (CK) 7, CK20, CAM5.2 was positive, and CK19 was negative, therefore the tumor was diagnosed as CLC. The diagnostic criteria have not been described clearly, so CLC is difficult to diagnose preoperatively. Further studies are needed to clarify the clinical and clinicopatholigical features of CLC.

Entities:  

Mesh:

Year:  2008        PMID: 18319561     DOI: 10.2152/jmi.55.161

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  11 in total

1.  A case of a large cholangiolocellular carcinoma.

Authors:  Moe Kadono; Kiminori Kimura; Jun Imamura; Shunichi Saeki; Masanao Kurata; Goro Honda; Koji Tsuruta; Shinichiro Horiguchi; Seishu Hayashi
Journal:  Clin J Gastroenterol       Date:  2011-08-07

2.  Intrahepatic cholangiocellular carcinoma and hepatocellular carcinoma developed after a 6-year sustained virological response to interferon therapy for chronic hepatitis C.

Authors:  Shinji Takashimizu; Sei-Ichiro Kojima; Junko Nagata; Yasuhiro Nishizaki; Tatehiro Kagawa; Koichi Shiraishi; Tetsuya Mine; Jun-Ichi Kaneko; Norihiro Kokudo; Norihito Watanabe
Journal:  Clin J Gastroenterol       Date:  2011-03-24

3.  CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.

Authors:  Mitsuo Shimada; Koji Sugimoto; Shuichi Iwahashi; Tohru Utsunomiya; Yuji Morine; Satoru Imura; Tetsuya Ikemoto
Journal:  J Gastroenterol       Date:  2010-04-09       Impact factor: 7.527

4.  S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report.

Authors:  Takashi Yamaguchi; Toshihito Seki; Ryosuke Inokuchi; Rinako Kawamura; Miki Murata; Koichi Matsuzaki; Osamu Nakashima; Tsutomu Kumabe; Kazuichi Okazaki
Journal:  Mol Clin Oncol       Date:  2016-10-11

5.  Successful surgical resection of ruptured cholangiolocellular carcinoma: A rare case of a primary hepatic tumor.

Authors:  Shota Akabane; Takushiro Ban; Shunsaku Kouriki; Hiroyuki Tanemura; Haruhiro Nakazaki; Masayuki Nakano; Nobuaki Shinozaki
Journal:  World J Hepatol       Date:  2017-06-08

6.  A case of cholangiolocellular carcinoma asynchronously developing 3 years after the resection of hepatocellular carcinoma.

Authors:  Masaya Iwamuro; Hirofumi Kawamoto; Tsuneyoshi Ogawa; Takehiro Tanaka; Takahito Yagi; Kazuhide Yamamoto
Journal:  Clin J Gastroenterol       Date:  2009-02-11

7.  Primarily screening and analyzing ESTs differentially expressed in rats' primary liver cancer.

Authors:  Dandan Liu; Lijuan Zhi; Mingxia Ma; Dan Qiao; Meijuan Wang; Yawei Wang; Baijie Jin; Anqi Li; Guting Liu; Yiqing Zhang; Yanyan Song; Hongxu Zhang
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

8.  Giant Cholangiolocellular Carcinoma With Early Recurrence That Was Difficult to Distinguish From Cholangiocellular Carcinoma: Report of a Case.

Authors:  Norihiro Ishii; Hideki Suzuki; Mariko Tsukagoshi; Akira Watanabe; Norio Kubo; Kenichiro Araki; Satoshi Wada; Hiroyuki Kuwano
Journal:  Int Surg       Date:  2015-06

9.  Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study.

Authors:  Qian Zhao; Wen-Long Yu; Xin-Yuan Lu; Hui Dong; Yi-Jin Gu; Xia Sheng; Wen-Ming Cong; Meng-Chao Wu
Journal:  Chin J Cancer       Date:  2016-08-24

10.  Cholangiolocellular Carcinoma in a Young Patient Who Showed Sustained Virological Response after Treatment for Hepatitis C Virus Infection.

Authors:  Mitsutaka Osawa; Satoshi Saitoh; Shunichiro Fujiyama; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Yoshiyuki Suzuki; Fumitaka Suzuki; Kenji Ikeda; Keiichi Kinowaki; Takeshi Fujii; Toshio Fukusato; Fukuo Kondo; Hiromitsu Kumada
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.